Literature DB >> 25825569

Time Dependent Release of Interleukin-8 and Tumor Necrosis Factor-α in Platelet Concentrate.

Rinku V Shukla1, Tanvi G Patel1, Snehalata C Gupte1.   

Abstract

Contaminating white blood cells in stored platelet concentrate (PC) are the source of many pro-inflammatory cytokines. These are implicated in transfusion reactions. To study the release of interleukin (IL)-8 and tumor necrosis factor alpha (TNF-α) at different time interval in PC prepared by-platelet rich plasma (PRP) and buffy coat (BC) using different principles. Fifteen PCs were prepared by both the methods. The supernatants of PCs prepared by PRP and BC methods were collected aseptically after 1, 18, 65 and 112 h of preparation. pH, platelet and WBC counts were done. The supernatants were frozen in aliquots at -56 °C for measurement of IL-8 and TNF-α concentration using ELISA. The Mean ± SD value of WBC in PRP-PC was 7.4 ± 3.75 × 10(7) and in BC-PC 3.9 ± 2.2 × 10(7). The mean platelet counts were 6.05 ± 1.94 × 10(10) and 6.54 ± 2.18 × 10(10) respectively. The highest level of IL-8 in one hour was up to 30 pg/ml in both the type of PC. It increased up to 986 pg/ml in PRP-PC and 481 pg/ml in BC-PC at 112 h. IL-8 increased significantly during storage period of 5 days in both types of PCs (P0.000 and P0.01). TNF-α level remained low up to 18 h. The highest level was 72 pg/ml in PRP-PC and 57 pg/ml in BC-PC at 65 h. IL-8 levels significantly increased after one hour of storage and TNF-α. levels were low up to 18 h and then showed increase. The BC-PC had significantly low levels of IL-8 compared to PRP-PC (P0.0001).

Entities:  

Keywords:  Buffy coat; Interleukin; Platelet concentrate; Platelet rich plasma; Tumor necrosis factor α

Year:  2014        PMID: 25825569      PMCID: PMC4375163          DOI: 10.1007/s12288-014-0435-8

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  19 in total

1.  Thrombocyte HLA molecules retain nonrenewable endogenous peptides of megakaryocyte lineage and do not stimulate direct allocytotoxicity in vitro.

Authors:  C Gouttefangeas; M Diehl; W Keilholz; R F Hörnlein; S Stevanović; H G Rammensee
Journal:  Blood       Date:  2000-05-15       Impact factor: 22.113

2.  Platelet storage time and cytokine (IL-2R, IL-8, TNF-alpha) levels.

Authors:  Z Bayraktaroglu; N Yilmaz; H K Cicek; A Karafak; E Gül
Journal:  East Mediterr Health J       Date:  2007 Jan-Feb       Impact factor: 1.628

3.  Use of leukocyte-depleted platelet concentrates for the prevention of refractoriness and primary HLA alloimmunization: a prospective, randomized trial.

Authors:  M van Marwijk Kooy; H C van Prooijen; M Moes; I Bosma-Stants; J W Akkerman
Journal:  Blood       Date:  1991-01-01       Impact factor: 22.113

4.  The immune response to allogeneic rat platelets; Ag-B antigens in matrix form lacking Ia.

Authors:  K I Welsh; H Burgos; J R Batchelor
Journal:  Eur J Immunol       Date:  1977-05       Impact factor: 5.532

5.  Quantitative measurements of platelet shape by light transmission studies; application to storage of platelets for transfusion.

Authors:  S Holme; S Murphy
Journal:  J Lab Clin Med       Date:  1978-07

6.  Generation of interleukin 8 in stored apheresis platelet concentrates and the preventive effect of prestorage ultraviolet B radiation.

Authors:  M Fujihara; T A Takahashi; C Ogiso; M Hosoda; K Ikebuchi; S Sekiguchi
Journal:  Transfusion       Date:  1997-05       Impact factor: 3.157

7.  Cytokine generation in stored platelet concentrate: comparison of two methods of preparation.

Authors:  Rajendra Chaudhary; Amita Aggarwal; Dheeraj Khetan; Rajeshwar Dayal
Journal:  Indian J Med Res       Date:  2006-10       Impact factor: 2.375

8.  The influence of platelet additive solutions on cytokine levels and complement activation in platelet concentrates during storage.

Authors:  R Cardigan; J Sutherland; M Wadhwa; P Dilger; R Thorpe
Journal:  Vox Sang       Date:  2003-01       Impact factor: 2.144

9.  Effect of filtration of platelet concentrates on the accumulation of cytokines and platelet release factors during storage.

Authors:  M T Aye; D S Palmer; A Giulivi; S Hashemi
Journal:  Transfusion       Date:  1995-02       Impact factor: 3.157

10.  A randomized controlled trial comparing the frequency of acute reactions to plasma-removed platelets and prestorage WBC-reduced platelets.

Authors:  Nancy M Heddle; Morris A Blajchman; Ralph M Meyer; Jeff H Lipton; Irwin R Walker; Graham D Sher; Lorrie A Constantini; Bruce Patterson; Robin S Roberts; Kevin E Thorpe; Mark N Levine
Journal:  Transfusion       Date:  2002-05       Impact factor: 3.157

View more
  1 in total

1.  Leucocyte cytokines dominate platelet cytokines overtime in non-leucoreduced platelet components.

Authors:  Chaker Aloui; Tahar Chakroun; Antoine Prigent; Saloua Jemni-Yacoub; Fabrice Cognasse; Sandrine Laradi; Olivier Garraud
Journal:  Blood Transfus       Date:  2016-09-08       Impact factor: 3.443

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.